On June 25, HJ Science-B rose 8.96% in regular trading, trading at 39.6 HKD/share, with turnover of 7.41 million HKD. The stock debuted on the Hong Kong Stock Exchange on June 23 at an IPO price of 81.8 HKD/share but suffered a dramatic 56.89% plunge on its first trading day, closing at 35.26 HKD. The current rebound comes after the stock lost more than half its value in a single session.
HJ Science-B was co-founded by multiple PhD-level scientists and is primarily engaged in the research, development, and production of innovative drugs targeting oncology, autoimmune diseases, and metabolic disorders.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)